Healthcare & Life Sciences Industry Updates

Google News – Pharmaceuticals External News

Disappointing Trial Results Hurt Regeneron Pharmaceuticals (REGN) in Q2 - Yahoo Finance

news.google.com · 14 Jul 2026

Google News – Biopharma External News

Argent Biopharma (ASX: RGT) Falls 15% and Is Down Nearly a Quarter Over the Year: Is the Micro-Cap Biotech Facing a Difficult Path? - Kalkine

news.google.com · 14 Jul 2026

Google News – Biopharma External News

Emcure to take full control of Gennova Biopharma with ₹232 crore stake acquisition - The Hindu

news.google.com · 14 Jul 2026

BBC Health External News

Ebola vaccine made in UK now ready for trials

bbc.co.uk · 14 Jul 2026

BBC Health External News

UK begins trials of Ebola vaccine developed in just eight weeks

bbc.co.uk · 14 Jul 2026

Industry News External News

Khader reviews Udupi hospitals, announces Rs 28 crore for healthcare: WATCH - newskarnataka.com

news.google.com · 14 Jul 2026

Industry News External News

More job titles include AI across every sector

hrdive.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

OKYO Pharma reports FDA feedback, advances urcosimod into Phase 3 trial for neuropathic corneal pain - Yahoo! Finance Canada

news.google.com · 13 Jul 2026

Google News – Clinical Trials External News

Breast Cancer Vaccines: How Researchers Are Testing Prevention in Clinical Trials - Breast Cancer Research Foundation | BCRF

news.google.com · 13 Jul 2026

Google_site External News

Clinical Research Coordinator - SingHealth Careers

news.google.com · 13 Jul 2026

Industry News External News

Psomagen, Cell Biotech sign MOU for microbiome biz - The Korea Herald

news.google.com · 13 Jul 2026

Google News – Oncology External News

GSK’s licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population - GSK

news.google.com · 13 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death - Fierce Biotech

news.google.com · 13 Jul 2026

Google News – FDA (biotech/pharma) External News

OKYO Pharma reports FDA feedback, advances urcosimod into Phase 3 trial for neuropathic corneal pain - Proactive financial news

news.google.com · 13 Jul 2026

Google News – FDA (biotech/pharma) External News

Ascelia Pharma Defends Orviglance Trial After FDA Rejection, Shares Plunge 79% in 2026 - finance.biggo.com

news.google.com · 13 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

Disappointing Trial Results Hurt Regeneron Pharmaceuticals (REGN) in Q2 - Yahoo Finance

Argent Biopharma (ASX: RGT) Falls 15% and Is Down Nearly a Quarter Over the Year: Is the Micro-Cap Biotech Facing a Difficult Path? - Kalkine

Emcure to take full control of Gennova Biopharma with ₹232 crore stake acquisition - The Hindu

Ebola vaccine made in UK now ready for trials

UK begins trials of Ebola vaccine developed in just eight weeks

Khader reviews Udupi hospitals, announces Rs 28 crore for healthcare: WATCH - newskarnataka.com

More job titles include AI across every sector

OKYO Pharma reports FDA feedback, advances urcosimod into Phase 3 trial for neuropathic corneal pain - Yahoo! Finance Canada

Breast Cancer Vaccines: How Researchers Are Testing Prevention in Clinical Trials - Breast Cancer Research Foundation | BCRF

Clinical Research Coordinator - SingHealth Careers

Psomagen, Cell Biotech sign MOU for microbiome biz - The Korea Herald

GSK’s licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population - GSK

FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death - Fierce Biotech

OKYO Pharma reports FDA feedback, advances urcosimod into Phase 3 trial for neuropathic corneal pain - Proactive financial news

Ascelia Pharma Defends Orviglance Trial After FDA Rejection, Shares Plunge 79% in 2026 - finance.biggo.com